Valuation: Medicure Inc.

Market Cap 13.36M 9.42M 8.26M 7.61M 7.12M 888M 13.64M 91.46M 35.39M 439M 35.35M 34.58M 1.52B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 10.41M 7.34M 6.44M 5.93M 5.55M 692M 10.63M 71.3M 27.59M 342M 27.56M 26.96M 1.19B EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
72.7%
Yield 2024 *
-
Yield 2025 -
1 day+2.40%
1 week+6.67%
Current month+15.32%
1 month+15.32%
3 months+14.29%
6 months+5.79%
Current year+12.28%
1 week 1.2
Extreme 1.2
1.28
1 month 1
Extreme 1
1.28
Current year 0.85
Extreme 0.85
1.35
1 year 0.85
Extreme 0.85
1.43
3 years 0.63
Extreme 0.63
1.8
5 years 0.63
Extreme 0.63
1.8
10 years 0
Extreme 0
10.67
Manager TitleAgeSince
Chief Executive Officer 79 15/09/1997
Director of Finance/CFO - 01/06/2022
Chief Tech/Sci/R&D Officer - 01/07/2019
Director TitleAgeSince
Chairman 79 15/09/1997
Director/Board Member 92 28/02/2000
Director/Board Member 56 22/01/2013
Date Insider Type Main position Quantity % Market Cap.
28/03/25Option

Director

7,200 0.0690%
28/03/25Option

Chief Financial Officer

1,350 0.0129%
28/03/25Option

Chief Technology Officer

7,500 0.0719%
Change 5-day change 1-year change 3-year change Capi.($)
+2.40%+6.67%+2.40%-3.76% 9.42M
+0.33%+1.37%+63.66%+126.38% 55.63B
+0.82%+15.05%+79.52%+85.53% 52.25B
+1.36%+0.36%-14.52%-13.83% 23.07B
-1.04%+7.91%+3.91%+417.68% 22.41B
-0.18%+7.20%+31.37%-13.62% 17.32B
-1.10%+4.00%+29.97%-33.36% 15.94B
+2.89%+5.51%+25.42%+186.30% 13.77B
-3.35%+8.96%+134.32%+289.59% 13.47B
+1.31%+0.53%+27.83% - 12.43B
Average +0.34%+4.30%+38.39%+115.66% 22.63B
Weighted average by Cap. +0.26%+5.13%+48.50%+122.67%

Financials

2024 2025
Net sales 21.91M 15.44M 13.54M 12.48M 11.68M 1.46B 22.36M 150M 58.04M 720M 57.98M 56.71M 2.5B 28.86M 20.34M 17.83M 16.44M 15.39M 1.92B 29.45M 198M 76.44M 948M 76.37M 74.7M 3.29B
Net income -1.04M -732K -642K -592K -554K -69.08M -1.06M -7.11M -2.75M -34.14M -2.75M -2.69M -118M -7.1M -5M -4.39M -4.04M -3.78M -472M -7.24M -48.59M -18.8M -233M -18.78M -18.37M -809M
Net Debt -6.32M -4.45M -3.9M -3.6M -3.37M -420M -6.45M -43.25M -16.74M -208M -16.72M -16.35M -720M -2.94M -2.07M -1.82M -1.68M -1.57M -196M -3.01M -20.16M -7.8M -96.74M -7.79M -7.62M -335M
Logo Medicure Inc.
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
38
Date Price Change Volume
24/06/26 CA$1.280 +2.40% 550
22/06/26 CA$1.250 +4.17% 3,700